APPENDIX 2

Public Hearing

Monday, 29 April 2013

Mantra Hotel, 222 Russell Street, Melbourne

Witnesses

Dr Kenneth Harvey

Australian Medical Association (via teleconference)

Dr Steven Hambleton, Federal President

Medicines Australia

Ms Deborah Monk, Director Innovation and Industry Policy

Dr Dominic Barnes, Chair, Transparency Working Group

GlaxoSmithKline

Mr Geoff McDonald, General Manager and Board Member, Medicines Australia

Ms Lisa Maguire, Associate Director, Corporate Affairs

Department of Health and Ageing

Mr Peter Woodley, Assistant Secretary, Blood, Organ and Regulatory Policy Branch, Regulatory Policy and Governance

Therapeutic Goods Administration

Ms Philippa Horner PSM, Principal Legal Adviser